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Abstract
Significant inequalities in health between and within countries have been measured over the past
decades. Although these inequalities, as well as attempts to improve sub-standard health, raise
profound issues of social justice and the right to health, those working in the field of bioethics have
historically tended to devote greater attention to ethical issues raised by new, cutting-edge
biotechnologies such as life-support cessation, genomics, stem cell research or face transplantation.
This suggests that bioethics research and scholarship may revolve around issues that, while
fascinating and important, currently affect only a small minority of the world's population. In this
article, we examine the accusation that bioethics is largely dominated by Anglophone and
industrialized world interests, and explore what kinds of positive contributions a 'bioethics from
below' (as Paul Farmer calls it) can make to the field of bioethics in general. As our guide in this
exploration, we make use of some experiences and lessons learned in our collaborative bioethics
project in the Democratic Republic of Congo, Building Bioethics Capacity and Justice in Health. We
conclude that while there is some evidence of increased attention to bioethical challenges in
developing countries, this development should be further cultivated, because it could help expand
the horizons of the field and enhance its social relevance wherever it is practiced.
Introduction: bioethics and inequality in health
There are vast differences in health between low-income,
middle-income and high income countries around the
world, as well as significant differences in health within
these countries. Epidemiologists, health economists and
health policy makers typically express global health ine-
qualities in the form of differences between country
health (and health proxy) indicators such as life-expect-
ancy, maternal and child mortality, and average per capita
income. For example, there is more than a 2-fold differ-
ence in life expectancy between the top three countries
(Japan, 82.3 years; Hong Kong, China, 81.9 years; Iceland,
81.5 years) and the bottom three (Zambia, 40.5; Sierra
Leone, 40.7; Zimbabwe, 40.9) [1]. In terms of child mor-
tality (one year and younger), commonly considered an
indicator of country health or development, the worst
affected countries have rates more than 90 times higher
than those least affected. In regard to maternal mortality,
the lifetime risk of pregnancy-related death in Malawi is 1
in 7, as compared with 1 in 2800 in industrialized
nations[2]. As is well known, income is inversely related
to infant mortality and a host of other health indicators.
There is a 400-fold increase between average per capital
income among the richest and poorest countries, and
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increased in the past few decades, the differences at the
outer ends of the global income index have been widen-
ing significantly[3,4]. In addition, research has indicated
that not only does absolute poverty have a strongly nega-
tive impact on health, but the greater the disparity
between rich and poor in a given society, the worse the
health of the 'less fortunate' in such societies tends to be.
Inequality, as Norman Daniels puts it, is bad for your
health [5,6].
Given the importance of health as a human value, and the
traditional aspiration of bioethics to articulate universal
principles, one might predict that ethical issues related to
these appalling global disparities would feature very
prominently in bioethics scholarship and research. How-
ever, some commentators claim that (a) mainstream
bioethics research and scholarship is marked by excessive
attention on bioethical issues largely affecting the world's
more affluent countries and (b) that in the light of global
realities, the predominantly 'first-world' agenda of bioeth-
ics should change. Leigh Turner, for example, writes that
many of the questions that bioethicists address (such as
face transplantation, cessation of life-support, or prenatal
genetic diagnosis) are only intelligible in the contexts of
wealthy developed nations, and these topics appear 'triv-
ial' when compared to the kinds of health issues faced by
people in impoverished, developing countries. Unless
bioethics broadens its agenda, Turner writes, it risks
becoming a form of entertainment[7,8]. In a similar vein,
Paul Farmer writes that mainstream bioethics has largely
been focused on issues of personal autonomy in regard to
new developments in biotechnology, rather than the
problems of social justice arising from the growing
(health) gap between the world's rich and poor commu-
nities[9]. Steven Miles writes that the 'soul of bioethics'
has been rendered unhealthy partly by its tendency to
engage more with issues of assisted reproduction and gene
therapy than with the growing number of medically unin-
sured in America, minority and migrant health, the links
between health and human rights, or the political and
economic barriers preventing developing countries from
gaining greater access to essential medicines[10].
Does bioethics, as a field of research and scholarship, con-
centrate too much on 'problems of affluence' while
neglecting the bioethical problems prevalent in resource-
poor settings? And if so, should the agenda of bioethics be
broadened, and in what ways? In attempting to answer the
first question, it should be noted that there is currently lit-
tle empirical data on what topics are studied by bioethi-
cists or trends in bioethics scholarship over time. Borry et.
al. [11,12] have studied authorship of bioethics publica-
tions, and have concluded that peer-reviewed bioethics
journals describing themselves as 'international' largely
publish articles by authors from Anglophone developed
countries, particularly the United States, United Kingdom,
Australia and Canada. However, as Borry et. al. admit,
these findings do not in themselves show that the content
of bioethics research and scholarship is biased towards
the concerns, interests and perspectives of more affluent
nations, though it is plausible that the social, cultural and
class origins of bioethicists might significantly affect topic
selection and directions of scholarship and research. In a
recent study of trends in bioethics topics by Cohen et.
al[13], the authors suggest that 'favored subject matter' in
bioethics varies significantly over time due to legal contro-
versies, discussion saturation and epidemiological impor-
tance. One striking finding of this study was that the
number of publications on 'AIDS and ethics' rose from 16
during the period 1980–84 to a peak of 793 in the period
1990–94, and then sharply declined to 197 between 2000
and 2004. As the authors note, the interest in this topic
among bioethicists in this case is strongly related to the
epidemiology of HIV/AIDS in the United States. With
increased public health surveillance and prevention
efforts, the advent of (and access to) effective anti-retrovi-
ral treatment and the virtual disappearance of mother-to-
child transmission of HIV through prenatal testing poli-
cies, the prevalence of HIV/AIDS dropped dramatically in
the early 1990's, and the interest of bioethicists in the
topic of AIDS and ethics seems to have declined with it.
However, during this same period there were many mil-
lions of new HIV infections and AIDS-related deaths
worldwide, with widespread and devastating economic,
political and social effects. This suggests that HIV/AIDS
was of significant interest and concern to the mainstream
bioethics community when it significantly threatened the
developed world, but is a considerably less compelling
bioethics topic when HIV/AIDS affects poorer countries
elsewhere.
The plausibility of 'first-world bias' in bioethics is further
strengthened by relatively easily accessible data regarding
the agencies who fund the bulk of bioethics research, the
location of the vast majority of bioethics centers or pub-
lishing houses of bioethical journals[14]. It is probably
safe to claim that most bioethicists originate from and/or
work in developed countries. On the other hand, there is
currently no firm data on origins, education or location of
bioethicists, and the issue is further complicated by the
fact that those who deal with ethical issues arising from
health research, policy or practice may not self-identify as
'bioethicists' or publish their work in mainstream bioeth-
ics journals. In summary, while there is some credible evi-
dence in favor of a current 'first-world bias' in bioethics,
more empirical research should be conducted to evaluate
the claims of bias and parochialism that continue to be
made.Page 2 of 8
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regarding bioethics is more complex than is sometimes
depicted in 'first-world bias' claims. For example, in the
past decade, there has been a sharp increase in the number
of sophisticated biomedical institutions established in
India, partly a response to the demand for medical tour-
ism and the economic incentive to host large-scale clinical
trials. Researchers and physicians working in these institu-
tions are increasingly faced with standard 'first-world'
bioethics issues such as cessation of life-support and
death criteria in view of organ transplantation. In pockets
of even the poorest countries, such bioethics issues are not
trivial, and are likely to increase in relevance as the health
standards of developing countries rise. The situation is
similar with the bioethical issues surrounding assisted
reproductive technologies as these become more accessi-
ble in resource-poor settings[15]. To further complicate
the picture, controversial biomedical research on mother-
to-child HIV transmission in Africa and Asia during the
1990's raised the profile of bioethics issues in developing
countries in a number of important ways. The controversy
increased attention on the issue of the appropriateness of
placebo controlled trials in general when conducting clin-
ical trials in poor countries, the content and role of inter-
national declarations protecting research participants, and
the meaning of exploitation in the context of interna-
tional research. The controversy was also the likely origin
of the Nuffield Council on Bioethics' report The Ethics of
Research Related to Healthcare in Developing Countries
(2001), the Wellcome Trust's initiative to fund bioethics
research in developing countries (started in 2002), and
the International Research Ethics Education and Curricu-
lum Development Awards offered by the Fogarty Interna-
tional Center at the National Institutes of Health
(launched in 2000), which is responsible for training
health professionals in bioethics and research ethics rele-
vant to developing world contexts at 18 institutions
worldwide. The European and Developing Countries
Clinical Trials Partnership (EDCTP) has offered funds for
establishing ethics review committees and bioethics edu-
cational programs in sub-Saharan Africa. Developing World
Bioethics, a peer-reviewed journal launched in 2001, is
devoted entirely to bioethics issues relevant to resource-
poor settings and has become an important target journal
for those working in this field. There is increasing talk of
African[16-18], Muslim[19,20] or Buddhist[21,22]
bioethics, and predictably, renewed challenges to the idea
of universal bioethics principles applicable to all cultural
contexts [23-25].
In short, while developed world topics, institutions and
authors still tend to be predominant, the global bioethics
landscape is slowly changing. What then are some key
concerns that tend to be marginalized within the main-
stream bioethics community but are more prominent in
developing world contexts? We will explore this question
through the prism of a collaborative bioethics program we
have helped establish in Kinshasa, Democratic Republic
of Congo.
Centre Interdisciplinaire de Bioéthique pour L'Afrique 
Francophone (CIBAF) at the Kinshasa School of Public 
Health
The Democratic Republic of Congo (DRC) covers the larg-
est geographical area (> 900,000 miles) and has the largest
population (approximately 63 million) of all Francoph-
one African countries, and is the second largest French-
speaking country in the world. Its capital city, Kinshasa, is
estimated to have a population of 8.9 million, making it
the second largest city in sub-Saharan Africa, and the third
largest city on the African continent after Lagos and Cairo.
This former Belgian colony is economically and politically
crucial to the sub-Saharan African region, but is only
slowly recovering from decades of political oppression
and mismanagement, violent civil conflict, and economic
exploitation of its natural resources. The legacy has left
many essential sectors, particularly education and medi-
cine, in a state of disarray[26].
In 2004, the University of North Carolina-Chapel Hill, the
University of Louvain (Belgium) and the Kinshasa School
of Public Health applied for what was then called an Inter-
national Bioethics Education and Career Development Award
from the Fogarty International Center at the National
Institutes of Health. The stated main purposes of the grant
are (a) to improve the quality of international research
ethics training (i.e. develop courses on bioethics and
research ethics issues affecting resource-poor countries)
and (b) to support advanced training of health care and
other professionals from resource-poor countries, in order
to improve ethical review of biomedical or public health
research conducted in such settings. In our application for
this grant, we proposed to train a small core of Congolese
scholars in Belgium and/or the United States, who would
establish and manage a center for bioethics at the Kin-
shasa School of Public Health on their return to the DRC.
The center, later named the Centre Interdisciplinaire de
Bioethique pour L'Afrique Francophone (CIBAF) was con-
ceived as a place for research ethics and bioethics research,
scholarship, education and consultation, focusing in par-
ticular on ethical issues faced in biomedicine and public
health research, policy and practice in sub-Saharan Fran-
cophone Africa. The Fogarty project we proposed, entitled
'Strengthening Bioethics Capacity and Justice in Health',
was approved for initial funding in 2004 and renewed
funding in 2008.
Why strengthen bioethics and research ethics capacity in
the DRC, given its troubled social, economic and political
context? There have been some sharp criticisms of FogartyPage 3 of 8
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bioethics training of professionals from developing coun-
tries constitutes 'ideological transfer' of Western values,
and the hidden agenda of the program is to facilitate US
federally funded biomedical and public health research in
resource-poor countries [27]. In our experience, these crit-
icisms have limited application and relevance. 'Ideologi-
cal transfer' tends to fade in the face of local values,
realities and practical constraints, and we have managed
to ensure that medical ethics and public health ethics –
not just research ethics – retains a prominent role within
CIBAF activities. For us, the bottom line is that – often in
the face of tremendous challenges – medicine, public
health interventions and biomedical research are con-
ducted in Francophone African countries, complex ethical
issues regularly arise from them, and explicit discussion of
these issues is still rare in medical, in popular media,
among NGOs or in local communities and other stake-
holders. CIBAF takes a social justice perspective on these
issues, befitting a context where the sub-standard health
of the vast majority is clearly linked to man-made histori-
cal, social, cultural, economic and political forces. In the
DR Congo, it is clear that many local bioethics and
research ethics issues are ultimately rooted in unjust forms
of inequality, and this consideration undermines any pos-
sibility for local bioethics to remain 'politically neutral'.
Bioethical reflection on the problems stemming from
health inequalities, including efforts to overcome them, is
itself a form of political commentary.
Ethical challenges raised by the struggle to improve health 
in resource-poor countries
In order to offer some examples of these ethical chal-
lenges, it is first important to ask: what are some of the
most important ways of reducing global health inequali-
ties? In what follows, we will briefly discuss what we see
as prominent ethical challenges in five important and
interrelated approaches to reducing global inequalities by
improving health in resource-poor countries: (1) global
health research, (2) implementation of tested health
interventions, (3) changing of health policies, (4)
strengthening of health care infrastructure, and (5) tack-
ling upstream forces impacting on health.
Global health research
The general goal of clinical and public health research is
to produce new, reliable information which could be used
to improve the health conditions of individuals and/or
populations. Prevention of mother-to-child HIV transmis-
sion research in the 1990's vividly demonstrated how pur-
suit of this worthwhile goal can raise ethical controversies
in low-income countries[28,29]. The University of North
Carolina at Chapel Hill and the Kinshasa School of Public
Health currently conducts operational research on effec-
tive and appropriate provision of anti-retroviral treatment
to HIV-positive persons in Kinshasa. Operational research
– sometimes called implementation research – is consid-
ered a crucial preliminary stage in the process of integrat-
ing health interventions effectively and sustainably into
health systems[30]. However, when the researchers
wanted to involve HIV-positive minors (less than 18 years
old) in their study, they ran into an ethical and regulatory
quandary. On the one hand, local physicians informed
the research team that minors are rarely told their HIV sta-
tus by their parents or doctors. On the other hand, US reg-
ulations state that Institutional Review Boards have the
discretion to require assent from minors when they partic-
ipate in research. How could meaningful assent be
obtained from minor participants – some of whom were
already in their early and mid-teens – for HIV-related
research without thereby disclosing their HIV-status to
them? And is assent considered culturally appropriate by
parents, guardians and local health care providers? How
does the concept of assent – originating in the idea of the
children's rights – relate to local conceptions of the rela-
tionship between parents and children in the context of
medical decision-making? The involvement of HIV-posi-
tive children and adolescents in this operational research
study would be undoubtedly beneficial for the partici-
pants, since those who need it would be provided with
treatment known to be effective and to which only a small
minority of children (or adults) currently have access in
the Democratic Republic of Congo. While involving HIV-
positive children in this research raises problems from an
ethical and regulatory perspective, not involving them
would be akin to the withholding of known effective treat-
ment.
In response to this problem, qualitative research on issues
surrounding pediatric assent and disclosure in HIV-
related research was conducted among parents, guardians,
physicians and young HIV-positive adults. The results of
this research are or will be published elsewhere [31,32],
but the main findings were that most youth interviewed
believed minors participating in HIV-related research
should be informed of their HIV-positive status, while
parents/caregivers had varied perspectives on if and when
HIV status should be disclosed to minors during research
participation. The age of the youth influenced parents'/
caregivers' responses, and disclosure to adolescents was
more frequently supported than disclosure to children.
Several parents/caregivers suggested that minors should
never be told their HIV-positive status when participating
in HIV-related research regardless of their age. The impli-
cations of these results for policy-making on pediatric
assent and disclosure in HIV-related research and clinical
practice were discussed in a workshop among a number of
local stakeholders, including members of CIBAF, the Min-
istry of Health, the National AIDS Control Program and
local health NGOs. In the case of the ongoing operationalPage 4 of 8
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requirement for the children's involvement in the
research, disclosure of HIV status should be regarded as an
ultimate goal for all HIV-positive youth (particularly as
they become sexually active), and a gradual and individu-
alized process of disclosure should be initiated for each
child involving parents, physicians and psychosocial
assistants. Our point here is not so much to weigh in on
this particular case, but to give a taste of the kinds of sci-
entific, cultural and ethical controversies that are part and
parcel of health research in low-income countries. Of all
ways of reducing global health inequalities, health
research receives the most bioethical attention[33].
Implementation of tested interventions
The fact that many health interventions, already shown to
be effective, have not been implemented in many low-
income countries is itself a matter of (longstanding) seri-
ous ethical concern[34]. Millions of deaths and disabili-
ties in these countries occur due to conditions we already
know how to prevent or treat. But when one tries to buck
this trend, new ethical challenges emerge. For example,
there have recently been global initiatives (such as PEP-
FAR and the Global Fund) to increase access to AIDS treat-
ment in low-income countries. Programs funded by such
initiatives typically offer a package of services to those liv-
ing with HIV/AIDS and (sometimes) their close family
members. There are two major ethical challenges. First,
the rollout of greater access is gradual, and this means that
there is not enough treatment and services for all those
who stand to benefit from it. In short, treatment and serv-
ices in the short term have to be rationed, with the ethical
choices that rationing involves[35-37]. Second, when an
HIV-positive person and his/her family receive treatment
and services, this may only reach the tip of the iceberg.
HIV/AIDS is one – and perhaps not the most pressing – of
the health-related needs of the program's beneficiaries.
HIV-positive persons in low-income countries are vulner-
able in many ways: they may suffer from other health con-
ditions for which there is no local or affordable treatment,
like cancer or mental illness; their homes may be
destroyed by natural disasters or civil strife; they may be
children orphaned from their dead parents, or have to
take care of such children; and they may have more regu-
lar access to antiretroviral treatment than they do to the
food that helps them absorb it. Anecdotal reports of AIDS
patients selling their drugs to buy other medications for
their family members or for food indicate that there may
be differences in perception about health-related needs
and priorities on the part of global initiatives and local
communities. Programs with the goal of reducing global
health inequality by providing antiretroviral treatment
must decide to what extent they can (or are allowed by
their funders to) tackle these other needs. Such decisions
regarding 'ancillary care' in biomedical research always
have ethical dimensions and implications[38-40]. In Kin-
shasa, the members of CIBAF have established a monthly
ethics session with local research teams, and problems of
ancillary care responsibilities are highly prominent in
these discussions.
Changing health policies
Health policies, in general, aim to promote health by leg-
islating approaches to health prevention, treatment and
care. The general assumption is that health policies are not
just words on paper, but can have a real impact – espe-
cially when integrated into institutional procedures and/
or backed by the force of law – on how health interven-
tions are implemented in the real world. Health policies
may have a stronger or weaker evidence base, or more or
less appropriate in a given context, but that they can have
an impact on health is hard to seriously doubt. Altering
health policies is therefore another important means of
reducing global health inequalities, though again, such
changes can raise a network of ethical concerns and chal-
lenges. For example, take recent changes in HIV testing
policy. For decades, voluntary testing and counseling
(VCT) was the model for HIV testing policy around the
world. According to the policy as initially promoted, VCT
centers should be established that offer intensive pre- and
post-HIV test counseling for those who come to these
centers to learn about their HIV-status. This policy, stress-
ing individual choice and confidentiality of results, was
quite different from past policies regarding other serious
infectious diseases, and was likely shaped by the fact that
HIV first emerged among stigmatized populations (gay
men and injection drug users) who, because there were no
effective drugs yet, could not be treated once diagnosed
with HIV. With roughly 90% of HIV positive persons in
sub-Saharan Africa unaware of their HIV-status, and
increasing access to antiretroviral treatment, the World
Health Organization and the Centers for Disease Control
and Prevention now promote what they call 'provider-ini-
tiated' HIV testing policies. One such policy is 'opt-out'
HIV testing, whereby patients at clinics and hospitals are
told by staff that they will be tested for HIV unless they
explicitly decline testing. While the policy has the worth-
while goal of increasing the numbers of persons with
knowledge of their HIV status, there are ethical concerns
when the policy is promoted in low-income countries,
such as the DRC. For example, it is unclear to what extent
patients (particularly women) in these countries are capa-
ble of declining testing or whether the existence of an 'opt-
out' testing policy will lead people to avoid health clin-
ics[41,42]. The weighing of the burdens and benefits of
'provider initiated' testing is also more complicated when
those tested are not guaranteed access to HIV treat-
ment[43]. As studies are conducted on the impact of the
new HIV testing policies, and treatment access increases,
at least some of these ethical concerns may be identifiedPage 5 of 8
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argue for or against new changes in HIV testing policy, but
simply to indicate how changes in health policy trigger
complex ethical challenges in low-resource settings that
bioethicists, together with other stakeholders involved in
the improvement of health in developing countries, must
reckon with.
Strengthening health care infrastructure
Raising the standards of medical care in low-income
countries would go some way in reducing global health
inequalities. That health care services in some low-income
countries are less than adequate is well-known, and there
is growing acknowledgement that it is important to
strengthen local health infrastructure, in terms of medical
materials and supplies, organization and records-keeping,
as well as human resources. In regard to the latter, there is
a phenomenon one might call the 'brain-drain capacity-
building conundrum.' On the one hand, low-income
countries (particularly sub-Saharan Africa) have the low-
est nurse-patient and doctor-patient ratios in the world,
and therefore there is a great and urgent need for capacity-
building of health care professionals in these countries.
On the other hand, those training at institutions in low-
income countries are increasingly being lured by employ-
ment opportunities in more affluent countries, whose
demand for health care professionals is increasing as their
population ages. For example, out of an estimated 4000
nurses in active service in Malawi in 2005, 453 nurses who
had been trained in Malawi were reported to be working
in developed countries (mostly United Kingdom), repre-
senting 11.3% of the number of the active nurse work
force at the time[47].
There is additionally the internal brain drain, i.e. health
professionals abandoning the public health sector for
more lucrative and career-enhancing positions in the pri-
vate health sector, foreign-funded health research projects
or medical positions within non-governmental organiza-
tions. There is an ethical conflict between an individual's
right to seek better occupational circumstances for him- or
herself and responsibilities towards patients and support-
ive institutions in his/her country of origin and training.
Given this conundrum, those attempting to build capacity
among health professionals in low-income countries
(including our own efforts in the DRC) must ensure that
they are not contributing to the brain drain and making a
bad situation even worse. The 'push', 'pull' and 'grab' fac-
tors driving the brain drain[48,49], however, must also be
tackled at another level, factors having to do with eco-
nomic conditions in a global market, government policy
and international relations.
Tackling upstream factors
Debates about globalization have entered the domain of
public health with the acknowledgment that forces, tran-
scending the jurisdiction or control of any particular
country, profoundly impact on the health of populations.
These transnational forces may be responsible for some of
the inequalities in health worldwide. Some of these forces
include: mass migration due to wars; the international
arms and drug trades; the traffic in persons, including
women in the sex industry; international trade agreements
and policies; climate change, and its effects on disease
emergence, prevalence and distribution; international pri-
orities in research and development, including the large
proportion spent on military research; debt relationships
between high- and low-income nations; unsustainable
growth in consumption in high-income countries and
population in low-income ones; aggressive advertizing of
tobacco by multinational corporations in low-income
countries; changes in diets due to increasing trade in foods
high in fat and sugar; ecological destruction by extractive
industries[50]. Take for example the current global food
crisis. Global prices of basic foodstuffs have increased sig-
nificantly, plunging an estimated additional 100 million
people into extreme poverty, and the effects of the food
crisis on health will be disproportionately felt in low-
income countries. The complex of man-made factors
behind acute and chronic global health crises should be
critically investigated from a perspective integrating pub-
lic health research, bioethics, political economy, and his-
tory.
Those involved in governance, civil society, public health
and bioethics can contribute in different ways to the goal
of reducing global health inequalities by tackling these
upstream forces. Citizens can press their own govern-
ments, through collective action and mobilization, to ful-
fill their obligations of creating the social, economic and
political conditions for greater equality in health. Global
institutions, such as the United Nations, International
Monetary Fund, and the World Bank, have similar obliga-
tions in regard to global health inequalities[51,52]. Those
in public health can inform political efforts by rigorously
exploring the links between upstream factors and popula-
tion health. Those in bioethics can (for example) articu-
late core ethical values – expressing what Benatar calls a
'global state of mind' – to guide and evaluate political and
public health efforts to reduce gross disparities in health
among and within nations[53].
By way of conclusion: priorities in bioethics
Should global health inequalities, and the ethical issues
associated with them, feature more prominently in
bioethics discussions? As some point out, bioethicists
may balk at the suggestion that topic selection in bioethics
be anything other than a matter of personal choice[8].
However, as indicated in the opening sections, one can
question how personal these choices really are. The atten-
tion of bioethicists (as well as the popular medical) tends
to gravitate towards agonizing dilemmas of patients, fam-Page 6 of 8
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technology interventions also have a prominent profile in
bioethics discussions, and there is something of a bioeth-
ics fashion cycle as ethical reflections on newest inven-
tions (e.g. stem cell research, enhancement technologies,
facial transplants, gene transfer therapy) replace those that
have become less-than-fresh (e.g. dialysis, IVF, life-sup-
port). Bioethics also tends to align itself with whatever
topics are currently considered scientifically fundable;
unsurprisingly, many bioethicists have made the choice of
pursuing the ethics of stem cell research, genomics or bio-
terrorism during the last decade. The focus of bioethicists
on novel technologies may be non-accidentally related to
the potential market value of such technologies and the
interests of public and private funding institutions, which
may set money aside to study their ethical implications.
This is not to say that such issues are unimportant. The
point here is that the objection to the very idea of priority-
setting in bioethics is moot when there is already a social
and partly market-based de facto process of priority-setting
in place.
The question is whether it is desirable, or even ethically
justified, for bioethics to continue to reflect something
like a '90/10' gap, i.e. a situation where 90% of discus-
sions on bioethics in the literature and the popular media
may revolve around issues affecting 10% of the world's
population. This situation, as mentioned before, seems to
be slowly changing and these changes should be encour-
aged. But it is important to point out that the preoccupa-
tions of mainstream bioethics may not even be
representative of the range of possible issues within devel-
oped countries themselves. Bioethical questions related to
urban poverty, drug use, immigration, occupational haz-
ards in the workplace or environmental injustice make
only rare appearances in peer-reviewed bioethics journals,
course syllabi, and conferences. These areas of scholarship
– tightly linked to issues of social justice – may fall below
the radar of many bioethicists due to the social, class and
racial barriers between many practitioners of bioethics
and affected communities. Commonalities exist between
bioethical challenges familiar in the low-income coun-
tries and those in underserved or marginalized communi-
ties within more affluent nations, arising from historical
inequities, limited access to health care, racial discrimina-
tion, and gender violence. For this reason, greater atten-
tion to ethical issues arising from biomedical research,
clinical practice and public health interventions 'far away'
might have a positive effect on bioethics 'closer to home',
potentially expanding the horizons of the field and
enhancing its social relevance.
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